EdwardJamesTannerIIIMDMBA
Obstetrics & Gynecology • Bethesda, MDGynecologic Oncology
Vice Chair of Gynecology and Obstetrics in the National Capital Region, Johns Hopkins University School of Medicine
Dr. Tanner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10215 Fernwood Road
Bethesda, MD 20817Phone+1 202-243-5295Fax+1 202-537-4662
Education & Training
Johns Hopkins UniversityMBA, Business Administration, 2017 - 2021
Memorial Sloan Kettering Cancer CenterFellowship, Gynecologic Oncology, 2008 - 2012
Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 2004 - 2008
University of Alabama School of MedicineClass of 2004
Certifications & Licensure
DC State Medical License 2023 - 2026
IL State Medical License 2018 - 2026
VA State Medical License 2023 - 2026
MD State Medical License 2012 - 2025
FL State Medical License 2018 - 2020
NY State Medical License 2008 - 2013
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Excellence in Teaching Award Department of GYN/OB, Johns Hopkins University
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
Publications & Presentations
PubMed
- Stakeholder-informed refinement of a behavioral sleep/circadian intervention for gynecologic cancer survivors: an application of the MOST preparation phase.Rina S Fox, Krista Brandon, Terry A Badger, Julia S Gaumond, Ana Acuña Morales
Translational Behavioral Medicine. 2025-01-16 - 5 citationsConsensus on surgical technique for sentinel lymph node dissection in cervical cancer.Nicolò Bizzarri, Andreas Obermair, Heng-Cheng Hsu, Enrique Chacon, Anna Collins
International Journal of Gynecological Cancer. 2024-04-01 - Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer.Yinu Wang, Xiaolei Situ, Horacio Cardenas, Ellie Siu, Sayedabdulrazzaq A Alhunayan
Clinical Cancer Research. 2024-03-15
Professional Memberships
- Member
- Society of Gynecologic OncologyMember
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
